Binding molecules against sars-coronavirus and uses thereof
CA 2531684 C · Owner: Van Den Brink, Edward Norbert · Inventors: Van Den Brink, Edward Norbert; Goudsmit, Jaap; De Kruif, Cornelis Adriaan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules compositions , comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically binding to SARS-CoV and can be used in the diagnosis prophylaxis and/or treatment of , a condition resulting from SARS-CoV.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 21, 2004 and granted March 11, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 21, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 21, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.